Retraction: Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy (PLoS ONE (2019) 6:7 (e22244) DOI: 10.1371/journal.pone.0022244);Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  DeNiro, Michael ^a,b   Al Mohanna, Falah H ^b   Al Mohanna, Futwan A ^b  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GUANYLATE CYCLASE; HYPOXIA INDUCIBLE FACTOR 1; LIFICIGUAT; PLATELET DERIVED GROWTH FACTOR B; FURAN DERIVATIVE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; INDAZOLE DERIVATIVE; NERVE PROTEIN; OXYGEN; YC 1 COMPOUND; YC-1 COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; GENE OVEREXPRESSION; GLIA CELL; GLIOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISCHEMIC RETINOPATHY; MOUSE; MUELLER CELL; NEWBORN; NONHUMAN; PROTEIN LOCALIZATION; RETINA NEOVASCULARIZATION; RETINOPATHY; TREATMENT RESPONSE; UPREGULATION; ANIMAL; CELL CULTURE; CELL LINE; CELL MOTION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GLIA; METABOLISM; RETINA DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; FURANS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; INDAZOLES; MICE; NERVE TISSUE PROTEINS; NEUROGLIA; OXYGEN; PROTO-ONCOGENE PROTEINS C-SIS; RETINAL DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960318546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0227156     Document Type: Erratum

References (67)

1. Moss SE, Klein R, Klein BE, (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 6: 998-1003.
2. Russ PK, Gaylord GM, Haselton FR, (2001) Retinal vascular permeability determined by dual-tracer fluorescence angiography. Annals of Biomedical Engineering 8: 638-647.
3. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, et al. (1994) Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 324: 152-161.
4. Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB, (2000) Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Commun 6: 380-388.
5. Cunha-Vaz J, Faria de Abreu JR, Campos AJ, (1975) Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 11: 649-656.
6. Sasahara M, Fries JW, Raines EW, Gown AM, Westrum LE, et al. (1991) PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 1: 217-27.
7. Smits A, Odin P, Duan WM, Brundin P, Widner H, et al. (1993) Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts. Cell Transplant 2: 151-62.
8. Krupinski J, Issa R, Bujny T, Slevin M, Kumar P, et al. (1997) A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 3: 564-573.
9. Krupinski J, Issa R, Bujny T, Slevin M, Kumar P, et al. (1994) Platelet-derived growth factor B-chain-like immunoreactivity in injured rat brain. Brain Res 1-2: 131-40.
10. Seo MS, Okamoto N, Vinores MA, Vinores SA, Hackett SF, et al. (2000) Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol 3: 995-1005.
11. Campochiaro PA, Glaser BM, (1985) Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol 4: 576-579.
12. Takamiya Y, Kohsaka S, Toya S, Otani M, Mikoshiba K, et al. (1986) Possible association of platelet-derived growth factor (PDGF) with the appearance of reactive astrocytes following brain injury in situ. Brain Res 1-2: 305-309.
13. Bressler JP, Grotendorst GR, Levitov C, Hjelmeland LM, (1985) Chemotaxis of rat brain astrocytes to platelet-derived growth factor. Brain Res 344: 249-254.
14. Watanabe T, Raff MC, (1988) Retinal astrocytes are immigrants from the optic nerve. Nature 332: 834-837.
15. Kawasaki A, Otori Y, Barnstable CJ, (2000) Müller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest Ophthalmol Vis Sci 41: 3444-3450.
16. Rungger-Brändle E, Dosso AA, Leuenberger PM, (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41: 1971-1980.
17. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, et al. (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47: 815-820.
18. Pekny M, Levéen P, Pekna M, Eliasson C, Berthold CH, et al. (1995) Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 14: 1590-1598.
19. Yasuda Y, Tateishi N, Shimoda T, Satoh S, Ogitani E, et al. (2004) Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia. Brain Res 1: 20-31.
20. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, et al. (2006) Müller cells in the healthy and diseased retina. Prog Retin Eye Res 4: 397-424.
21. Sahel JA, Albert DM, Lessell S, (1990) Proliferation of retinal glia and excitatory amino acids. Ophtalmologie 4: 13-16.
22. Rutka JT, Smith SL, (1993) Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res 53: 3624-3631.
23. Jing R, Wilhelmsson U, Goodwill W, Li L, Pan Y, et al. (2007) Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks. J Cell Sci 120: 1267-1277.
24. Pekny M, Nilsson M, (2005) Astrocyte activation and reactive gliosis. Glia 50: 427-434.
25. Tackenberg MA, Tucker BA, Swift JS, Jiang C, Redenti S, et al. (2009) Müller cell activation, proliferation and migration following laser injury. Mol Vis 15: 1886-1896.
26. Reichenbach A, Faude F, Enzmann V, Bringmann A, Pannicke T, et al. (1997) The Müller (glial) cell in normal and diseased retina: a case for single-cell electrophysiology. Ophthalmic Res 29: 326-340.
27. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, et al. (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38: 36-47.
28. Yu AC, Lee YL, Eng LF, (1991) Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res 30: 72-79.
29. Yu AC, Lee YL, Eng LF, (1993) Astrogliosis in culture:I The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res 34: 295-303.
30. Lefrançois T, Fages C, Peschanski M, Tardy M, (1997) Neurite outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuronastrocyte cocultures. Journal of Neuroscience 17: 4121-4128.
31. Friebe A, Koesling D, (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93: 96-105.
32. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM, (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84: 4226-4233.
33. Dismuke WM, Sharif NA, Ellis DZ, (2009) Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel. Invest Ophthalmol Vis Sci 50: 3353-9.
34. Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM, (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116: 1973-1978.
35. Stone JR, Marletta MA, (1998) Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 5: 255-261.
36. Friebe A, Koesling D, (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 53: 123-127.
37. Brioni JD, Nakane M, Hsieh GC, Moreland RB, Kolasa T, et al. (2002) Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction. Int J Impot Res 14: 8-14.
38. DeNiro M, Al-Mohanna F, Al-Halafi A, Alsmadi O, Al-Mohanna FA, (2009a) Pleiotropic Effects of YC-1 Attenuates Pathological Retinal Neovascularization. Invest Ophthalmol Vis Sci; ARVO E-Abstract# 41 50: 2480.
39. DeNiro M, Al-Mohanna F, Al-Halafi A, Alsmadi O, Al-Mohanna F, (2010) Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol Pharmacol 3: 348-367.
40. DeNiro M, Alsmadi O, Al-Mohanna F, (2009b) Modulating the Hypoxia-Inducible Factor Signaling Pathway as a Therapeutic Modality to Regulate Retinal Angiogenesis. Experimental Eye Research 89: 700-717.
41. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111.
42. Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, et al. (2002) Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2: 496-502.
43. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL, (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
44. Yu X, Xu Z, Mi M, Xu H, Zhu J, et al. (2008) Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 3: 500-507.
45. Chen F, Mi M, Zhang Q, Wei N, Chen K, et al. (2010) Taurine buffers glutamate homeostasis in retinal cells in vitro under hypoxic conditions. Ophthalmic Res 2: 105-112.
46. Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, et al. (2007) Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 4: 429-439.
47. Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, et al. (1994) Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 35: 3649-3663.
48. Kim IB, Kim KY, Joo CK, Lee MY, Oh SJ, (1998) Reaction of Müller cells after increased intraocular pressure in the rat retina. Exp Brain Res 121: 419-424.
49. Eisenfeld AJ, Bunt-Milam AH, Sarthy PV, (1984) Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci 25: 1321-1328.
50. Erickson PA, Fisher SK, Guérin CJ, Anderson DH, Kaska DD, (1987) Glial fibrillary acidic protein in Muller cells after retinal detachment. Exp Eye Res 44: 37-48.
51. Hayashi A, Koroma BM, Imai K, de Juan E Jr, (1996) Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 11: 2146-2156.
52. Cox OT, Simpson DA, Stitt AW, Gardiner TA, (2003) Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol Vis 9: 665-672.
53. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, et al. (1999) Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40: 182-189.
54. Campochiaro PA, (2010) Molecular Targets for Retinal Diseases: Hypoxia-regulated genes play an important role in vascular permeability and neovascularization. Retina Today July/August (Supplement): 4-7.
55. Friedl P, Hegerfeldt Y, Tusch M, (2004) Collective cell migration in morphogenesis and cancer. Int J Dev Biol 5-6: 441-449.
56. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, et al. (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
57. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D, (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287-1295.
58. Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, et al. (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156: 697-707.
59. Seo MS, Kwak N, Ozaki H, Yamada H, Okamoto N, et al. (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol 154: 1743-1753.
60. Salhia B, Angelov L, Roncari L, Wu X, Shannon P, et al. (2000) Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res 1: 87-97.
61. Seifert V, Löffler BM, Zimmermann M, Roux S, Stolke D, (1995) Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1: 55-62.
62. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, et al. (1997) Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2: 287-93.
63. Zhang WW, Badonic T, Höög A, Jiang MH, Ma KC, et al. (1994) Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J Neurol Sci 1: 90-6.
64. Gadea A, Schinelli S, Gallo V, (2008) Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J Neurosci 10: 2394-408.
65. Koyama Y, Baba A, Matsuda T, (2007) Intracerebroventricular administration of an endothelin ETB receptor agonist increases expression of tissue inhibitor of matrix metalloproteinase-1 and-3 in rat brain. Neuroscience 3: 620-30.
66. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, et al. (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 4: 323-328.
67. Phillips GD, Stone AM, (1994) PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells. Mech Ageing Dev 73: 189-196.